The central insight of the review is a distinction between deficits within a phase and deficits at the transitions between phases. Aged skeletal muscle is impaired at every stage of post-injury repair that researchers have examined: immune cell recruitment is delayed and skewed in composition, the degradation of damaged debris lags behind its uptake, and muscle stem cells follow a broadly conserved activation trajectory but on delayed kinetics. Yet these within-phase problems may be differences of degree that a longer repair window can absorb. Transitions between phases offer no such slack. Each transition is triggered by a defined molecular switch, and if a compartment arrives late, it encounters a microenvironment already committed to a self-maintaining alternative state that its later output may be unable to reverse.

Three such switches anchor the repair sequence. The first is the fall in damage-related input that follows complete degradation of necrotic debris, which permits inflammation to begin resolving. The second is the balance between the inflammatory signal TNF and the profibrotic signal TGF-beta, which determines whether fibro-adipogenic progenitors, the stromal cells that temporarily support regeneration, undergo apoptosis and are cleared once their support phase ends. The third is the conversion of inflammatory Ly6C-high monocytes into reparative Ly6C-low macrophages, the immune pivot on which the shift from destruction to reconstruction depends. Because positive feedback loops operate beyond each of these switches, a lagging compartment does not simply slow the program; it can meet a tissue state that actively resists correction.

The review singles out retained mitochondrial lesions in postmitotic myofibers as one proposed input that can hold the first switch open. Skeletal muscle fibers are long-lived and cannot divide, so damaged mitochondrial DNA deletion mutations accumulate within individual fibers over decades, sometimes reaching detrimental levels intracellularly. These lesions can release mitochondrial DNA into the cytosol, where it activates the cGAS-STING innate immune pathway, a circuit that normally detects microbial DNA but misfires on self DNA. Mitophagy, the cellular quality-control system that normally removes damaged mitochondria, curtails this inflammatory activation in youth, but its capacity declines with age. The result is a persistent damage signal that keeps the injury phase of repair nominally alive even after the original wound has been cleared.

Meanwhile, the muscle stem cells themselves, the satellite cells that are absolutely required for regeneration, face a compounding set of problems. Their pool contracts with age, their fate allocation becomes skewed away from self-renewal, and they acquire cell-autonomous defects, including p38 MAPK-driven loss of self-renewal and p16- and p21-associated senescence, that persist even when aged cells are transplanted into a young host environment. Age-associated epigenetic changes can suppress genes such as SPRY1, causing stem cells to fail to return to quiescence and depleting the reserve pool needed for future injuries. The aged niche compounds this, with loss of fibronectin and WISP1 from fibro-adipogenic progenitors and stiffening of the extracellular matrix further degrading stem cell support.

The stromal compartment tells an equally troubling story. Fibro-adipogenic progenitors are essential early: they facilitate myogenesis, secrete supportive matrix proteins, and in youth are duly removed by TNF-triggered apoptosis once their job is done. In aged muscle, they resist clearance past their useful window, while the matrix around them stiffens and keeps pushing them toward a fibrogenic identity. Mechanotransduction studies show that substrate stiffness alone can drive progenitors into myofibroblasts, creating a feed-forward loop in which fibrosis begets more fibrosis. The same mechanical logic has been implicated in idiopathic pulmonary fibrosis, and the review argues that aged muscle may trap itself in an analogous self-reinforcing state from which no single late intervention can easily extract it.

The immune system completes the picture of desynchronization. Aged myeloid cells reach the pro-repair switch late and with attenuated output. Recruitment of inflammatory monocytes is delayed, their conversion to Ly6C-low reparative macrophages is blunted, and debris degradation lags behind phagocytic uptake, meaning material is swallowed but not fully digested. Regulatory T cells, which accumulate in injured muscle and potentiate repair through interleukin-33-dependent mechanisms, fail to accumulate properly in aged animals. The consequence is that when reparative macrophages and stem cells finally engage, the microenvironment has often already tipped toward chronic inflammation and matrix deposition, states maintained by their own positive feedback.

Crucially, the authors argue that none of these individual lesions need be the primary cause for the sequence to fail. This reframing has practical consequences for how regenerative interventions in aging should be judged. Rather than asking whether a therapy rescues one cell type in isolation, the review proposes evaluation against system-level criteria: does inflammation decline, does matrix remodeling close, does myogenic output yield mature fibers, and does the reserve stem cell pool survive repeated injury? Interventions that look promising in single-cell assays but leave transition timing intact failure would be expected to underperform, whereas approaches that restore coordination, even partially, may yield disproportionate benefit.

The framing also connects to a broader view of aging itself. Rather than a simple accumulation of damage in individual cells, aging here emerges as a systems-level breakdown in when things happen, not merely whether they happen. Sub-threshold delays, each individually tolerable, accumulate between compartments that must act in precise sequence, until one failed transition settles the tissue into an inflammatory-fibrotic endpoint that behaves like an alternative stable state. If this view is correct, future therapies for sarcopenia and poor healing in the elderly may need to target timing itself, restoring the ordered handoffs between macrophages, fibro-adipogenic progenitors, and stem cells, rather than simply boosting any one of them. The review, published as Volume 27, article 154 of Biogerontology, offers a conceptual scaffold for that next generation of studies.

Subject of Research: Temporal coordination failure, or phase-transition failure, in regeneration of aged skeletal muscle

Article Title: Phase-transition failure in aged skeletal muscle regeneration

Article References: Zhang, B., Shi, H., Guo, X., & Wang, Y. (2026). Phase-transition failure in aged skeletal muscle regeneration. Biogerontology, 27(5), Article 154. https://doi.org/10.1007/s10522-026-10500-6

Image Credits: AI Generated

DOI: 10.1007/s10522-026-10500-6

Keywords: skeletal muscle, aging, regeneration, muscle stem cells, satellite cells, macrophages, fibro-adipogenic progenitors, inflammation, fibrosis, mitochondrial DNA, cGAS-STING, sarcopenia